Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 4 of 57328 results
Sort by: relevance publication year
Showing results for ISSN matching 0923-7534

P-275 FOLFOX versus FOLFIRI as second-line treatment after cisplatin-gemcitabine in patients with advanced biliary tract cancers

JOURNAL ARTICLE published June 2023 in Annals of Oncology

Authors: F. Nichetti | M. Rizzato | M. Bensi | F. Salani | A. Franza | V. Piva | R. Cerantola | M. Chiaravalli | G. Masi | S. Ahcene Djaballah | D. Barone | C. Vivaldi | F. Bergamo | S. Rota | M. Di Bartolomeo | F. de Braud | M. Niger | S. Lonardi

https://doi.org/10.1016/j.annonc.2023.04.331 Actions

P-149 QUATTRO-II: A multicenter randomized trial comparing CAPOXIRI + bevacizumab with FOLFOXIRI + bevacizumab as first-line treatment in patients with metastatic colorectal cancer: Efficacy and safety analysis

JOURNAL ARTICLE published June 2023 in Annals of Oncology

Authors: M. Kotaka | H. Bando | H. Satake | D. Kotani | T. Hamaguchi | M. Shiozawa | T. Ikumoto | T. Masuishi | H. Yasui | Y. Kagawa | E. Oki | Y. Yamamoto | H. Kawakami | S. Boku | Y. Komatsu | H. Taniguchi | K. Muro | K. Yamazaki | T. Misumi | T. Yoshino | T. Kato | A. Tsuji

https://doi.org/10.1016/j.annonc.2023.04.205 Actions

P-25 Questionnaire-assisted surveillance strategy for patients with precancerous conditions of gastric cancer

JOURNAL ARTICLE published June 2023 in Annals of Oncology

Authors: S. He | W. Chen

https://doi.org/10.1016/j.annonc.2023.04.081 Actions

P-44 Developing small molecules to disrupt IL-17RB and MLK4 interaction for pancreatic cancer treatment

JOURNAL ARTICLE published June 2023 in Annals of Oncology

Research funded by Academia Sinica (AS-GC-110-MD03)

Authors: C. Hu | I. Chen | Y. Ko | J. Lee | Y. Lo

https://doi.org/10.1016/j.annonc.2023.04.100 Actions

P-343 The impact of genomic alterations on response rate and survival outcomes in advanced BTC patients who receive cisplatin/gemcitabine plus durvalumab in clinical practice

JOURNAL ARTICLE published June 2023 in Annals of Oncology

Authors: M. Rimini | M. Rizzato | L. Rimassa | M. Niger | L. Fornaro | L. Antonuzzo | E. Martinelli | I. Garajová | A. Pastorino | G. Giordano | M. Schirripa | M. Silletta | A. Diana | A. Casadei Gardini

https://doi.org/10.1016/j.annonc.2023.04.399 Actions

Digital therapeutics for remote symptom monitoring and management in cancer care: the current and future state

JOURNAL ARTICLE published August 2023 in Annals of Oncology

Authors: E. Basch

https://doi.org/10.1016/j.annonc.2023.06.003 Actions

P-63 Real-world UK retrospective multi-centre review of the use of G-CSF in the prevention of chemotherapy-induced neutropenia in patients with CRC receiving trifluridine/tipiracil

JOURNAL ARTICLE published June 2023 in Annals of Oncology

Authors: I. Purcell | H. Brooks | S. Gangadhara | V. Kunene | P. Teo | M. Malik | L. Bell | V. Potter

https://doi.org/10.1016/j.annonc.2023.04.119 Actions

P-146 Efficacy and safety of FLOT combined with apatinib and sintilimab as a neoadjuvant therapy regimen for locally advanced gastric or gastroesophageal junction adenocarcinoma: An open-lable, single-arm, phase II study

JOURNAL ARTICLE published June 2023 in Annals of Oncology

Authors: H. Zhou | B. Long | Z. Yu | J. Zhu | H. Yang | W. Zhang | X. Guan | G. Zhang | L. Li | C. Luo | H. Cao | S. Zhang | S. Chen | Q. He | S. Gan | L. Zhou | X. Jiang | W. Shi | Z. Huang | J. Mao | C. Dong | Z. Jiao

https://doi.org/10.1016/j.annonc.2023.04.202 Actions

SO-3 Clinical relevance and actionability of BRAF alterations in advanced biliary tract cancer: Preliminary results from the multicenter B-REAL study

JOURNAL ARTICLE published June 2023 in Annals of Oncology

Authors: M. Niger | F. Nichetti | S. Murgioni | V. Zanuso | C. Bagalà | G. Masi | E. Gusmaroli | E. Perissinotto | A. De Rosa | R. Balsano | M. Bensi | V. Genovesi | G. Pruneri | L. Rimassa | L. Salvatore | C. Vivaldi | F. Bergamo | F. Pietrantonio | F. de Braud | S. Lonardi

https://doi.org/10.1016/j.annonc.2023.04.475 Actions

289P Results of the window-of-opportunity clinical trial D-BIOMARK: Study of biomarkers of the antitumor activity of denosumab and its role as a modulator of the immune response in early breast cancer

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: A. Vethencourt | E.M. Trinidad | E. Dorca Duch | A. Petit | M.T. Soler-Monsó | E. Purqueras | M.E. Brizzi | M. Matas Garcia | G. Pérez-Chacón | M. Jimenez | M. Ciscar | A. Stradella | A. Iserte | A. Gumà Martinez | R. Ortega | M.J. Gil | S. Pernas Simon | C. Falo | E. Gonzalez-Suarez

https://doi.org/10.1016/j.annonc.2023.09.486 Actions

484P Multi-platform characterization of HER2 expression in triple-negative breast cancer

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: A.C. Garrido-Castro | J. Gomez Tejeda Zanudo | J. Navarro | E.T. Richardson | A. Frangieh | A.M. Barkell | A. Mohammed-Abreu | M.E. Hughes | B. Binboga Kurt | T.A. King | E.A. Mittendorf | D. Carroll | S.M. Tolaney | E.C. De Bruin | N.U. Lin

https://doi.org/10.1016/j.annonc.2023.09.660 Actions

2276P Regulation of major histocompatibility class-I gene methylation using DNA methyltransferase inhibitor and PD-L1 inhibitor in triple-negative breast cancer

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Research funded by Ministry of Science, ICT and Future Planning (2020R1G1A1099646)

Authors: Y.J. Jeong | H.K. Oh

https://doi.org/10.1016/j.annonc.2023.09.1304 Actions

896P Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: K. Wang | L. Gui | H. Lu | X. He | D. Li | C. Liu | S. Liu | X. Wang

https://doi.org/10.1016/j.annonc.2023.09.2041 Actions

1711P The DRUP-like clinical trials family: A distributed European trial network for equitable access to precision medicine

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: H. Gelderblom | A. Edsjö | H.E.G. Russnes | U.N. Lassen | A. Helland | E. Hallersjö Hult | B. Ryll | I. Lugowska | J-Y. Blay | R.S. Falk | S. van Waalwijk van Doorn-Khosrovani | K. Steen Carlsson | K. Peltola | A. Stenzinger | E. Vrdoljak | J. Oliveira | S.F. Haj Mohammad | H.M.W. Verheul | E.E. Voest | K. Tasken

https://doi.org/10.1016/j.annonc.2023.09.2665 Actions

194P Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: D. Barth | F. Moik | S.M. Steinlechner | F. Posch | V. Schlintl | L. Koch | N. John | R. Wurm | M. Pichler | T. Bauernhofer | P. Reimann | C. Wohlkönig | E. Richtig | T. Winder | M. Preusser | P.J. Jost | C. Ay | A. Gerger | A. Terbuch | J.M. Riedl

https://doi.org/10.1016/j.annonc.2023.09.2917 Actions

Trastuzumab deruxtecan for breast cancer: do patients experience a comprehensive benefit?

JOURNAL ARTICLE published July 2023 in Annals of Oncology

Authors: F. Mosele | M. Di Maio

https://doi.org/10.1016/j.annonc.2023.05.011 Actions

191P Novel approach to proficiency testing demonstrates wide gaps in biomarker quality for colon cancer treatment

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: K.R. Bisson | A. Beharry | M.D. Carter | S. Dudani | J.G. Garratt | J.M. Loree | S. Snow | S. Yip | J.R. Won | B.S. Sheffield

https://doi.org/10.1016/j.annonc.2023.09.2915 Actions

251P Body mass index as a predictive factor for efficacy of taxane-based chemotherapy in early breast cancer patients

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: J.A. García-Sáenz | G. Spera | M.A. Pollán | B. Bermejo | M. Ruiz Borrego | A. Chan | M. Martin Jimenez | A.L. Guerrero Zotano | L. Calvo-Martinez | A. Rodríguez-Lescure | A. Arcusa Lanza | L.I. Chap | J.P. Crown | V. Bee-Munteanu | M. Casas | O. Polonio | D. Slamon

https://doi.org/10.1016/j.annonc.2023.09.448 Actions

742MO Neoadjuvant immune checkpoint blockade in mismatch repair deficient endometrial cancer

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Authors: M. de Bruyn | A.L. Eerkens | K. Brummel | A. Vledder | S.T. Paijens | M. Requesens | D. Loiero | N. van Rooij | A. Plat | P. Klok | F-J. Haan | D.N. Church | R. Wardenaar | F. Foijer | V.H. Koelzer | T. Bosse | J. Bart | M. Jalving | A.K.L. Reyners | H.W. Nijman

https://doi.org/10.1016/j.annonc.2023.09.1921 Actions

54P Enhanced oxidative phosphorylation of metastasis-initiating cells facilitates esophageal tumor cell seeding in lymph nodes

JOURNAL ARTICLE published October 2023 in Annals of Oncology

Research funded by National Natural Science Foundation of China (82072731,82072738,82103643)

Authors: S. Li | B. Zhang | C. Huang | X. Guan

https://doi.org/10.1016/j.annonc.2023.09.1555 Actions
Feedback: support@crossref.org